BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35717809)

  • 1. Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis.
    Chen M; Liu M; Guo X; Zhou J; Yang H; Zhong G; Men L; Xie Y; Tong G; Liu Q; Luan J; Zhou H
    Phytomedicine; 2022 Sep; 104():154243. PubMed ID: 35717809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
    Chen M; Zhong G; Men L; Liu Q; Luan J
    Medicine (Baltimore); 2021 Nov; 100(46):e27912. PubMed ID: 34797346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xinkeshu for coronary heart disease complicated with anxiety or depression: A meta-analysis of randomized controlled trials.
    Liu Q; Wang M; Wang H; Xie H; Han J; Chen J; Yu P; Shen L; Li Y; Tian R; Chen X
    J Ethnopharmacol; 2023 Aug; 312():116486. PubMed ID: 37072088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Chinese Herbal Medicine for Depressive Disorder in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Xue YJ; Xie Y; Zhao GL; Zhou BD; Li K; Li SY; Zhang P
    Chin J Integr Med; 2020 Aug; 26(8):617-623. PubMed ID: 31222629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Xinkeshu in the treatment of angina pectoris of coronary heart disease: A protocol for systematic review and meta-analysis.
    Fan M; Guo D; Wang Y; Liu Y; Zhao J; Yu Z
    Medicine (Baltimore); 2021 Oct; 100(40):e27407. PubMed ID: 34622846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
    Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
    Cochrane Database Syst Rev; 2013 May; (5):CD009581. PubMed ID: 23728695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris.
    Chen M; Men L; Wu H; Zhong G; Ou L; Li T; Guo Y; Lin H; Zhang J; Wang D; Zhang Z
    Medicine (Baltimore); 2019 Dec; 98(51):e18375. PubMed ID: 31860998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis.
    Liu Q; Dong T; Xi M; Gou L; Bai Y; Hou L; Li M; Ou L; Miao F; Wei P
    Evid Based Complement Alternat Med; 2021; 2021():9413704. PubMed ID: 34335841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis.
    Mao W; Lu P; Wan R; Mao K; Lv Y; Hu J; Fu Z; Wang J
    Front Cardiovasc Med; 2023; 10():1100006. PubMed ID: 37351285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Chung VC; Qin Y; Huang Y; Tam WW; Kwong JS; Xie W; Tang JL
    Cochrane Database Syst Rev; 2015 May; (5):CD010237. PubMed ID: 25994229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Danhong injection on endothelial function and inflammatory factors after the percutaneous coronary intervention for coronary heart disease: A protocol of systematic review and meta-analysis of randomized controlled trials.
    Li S; Duan S; Ning Y; Zhang H; Zheng Q
    Medicine (Baltimore); 2020 Jul; 99(27):e20783. PubMed ID: 32629660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Xinkeshu tablets on depression and anxiety symptoms in patients with coronary artery disease: Results from a double-blind, randomized, placebo-controlled study.
    Ma H; Wang Y; Xue Y; Huang D; Kong Y; Zhao X; Zhang M
    Biomed Pharmacother; 2019 Apr; 112():108639. PubMed ID: 30784924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of traditional Chinese exercise on cardiac rehabilitation after percutaneous coronary intervention: study protocol for network meta-analysis of randomised controlled trials.
    Luo C; Wen J; Sun W; Li T; Yu X; Zhang T; Zhou X; Wu W; Li R
    BMJ Open; 2019 Feb; 9(2):e023096. PubMed ID: 30782873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjunctive therapy of xuezhikang capsule for coronary heart disease: a systematic review and meta-analysis of randomized controlled trials].
    Wang Y; Chen ZH; Liu GH; Zhang F; Zhang Z; Guan XF; Luo ZB; Yang GL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1182-91. PubMed ID: 25509259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study.
    Wang CL; Huan N; Wang PL; Geng QS; Ma WL; Ma LH; Jiang HY; Meng XP; Zhang DW; Gou XJ; Hu DY; Chen KJ
    Chin J Integr Med; 2023 Mar; 29(3):195-204. PubMed ID: 36301456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review.
    Hu J; Qiu R; Li C; Li M; Dai Q; Chen S; Zhao C; Shang H
    BMC Complement Med Ther; 2021 Aug; 21(1):217. PubMed ID: 34465313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
    J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Music for stress and anxiety reduction in coronary heart disease patients.
    Bradt J; Dileo C; Potvin N
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006577. PubMed ID: 24374731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.